Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review.

Antirheumatic Agents / pharmacology Betacoronavirus COVID-19 Comorbidity Coronavirus Infections / diagnosis Humans Immunocompromised Host Pandemics Pneumonia, Viral / diagnosis Rheumatic Diseases / drug therapy Risk Assessment SARS-CoV-2 Severity of Illness Index
Adverse event Antirheumatic medications COVID-19 Immunosuppressive treatment Rheumatic disease SARS-CoV-2

Journal

Seminars in arthritis and rheumatism
ISSN: 1532-866X
Titre abrégé: Semin Arthritis Rheum
Pays: United States
ID NLM: 1306053

Informations de publication

Date de publication:
10 2020
Historique:
received: 12 06 2020
revised: 20 07 2020
accepted: 21 07 2020
pubmed: 16 9 2020
medline: 6 11 2020
entrez: 15 9 2020
Statut: ppublish

Résumé

COVID-19 is an acute respiratory viral infection that threatens people worldwide, including people with rheumatic disease, although it remains unclear to what extent various antirheumatic disease therapies increase susceptibility to complications of viral respiratory infections. The present study undertakes a scoping review of available evidence regarding the frequency and severity of acute respiratory viral adverse events related to antirheumatic disease therapies. Online databases were used to identify, since database inception, studies reporting primary data on acute respiratory viral infections in patients utilizing antirheumatic disease therapies. Independent reviewer pairs charted data from eligible studies using a standardized data abstraction tool. A total of 180 studies were eligible for qualitative analysis. While acknowledging that the extant literature has a lack of specificity in reporting of acute viral infections or complications thereof, the data suggest that use of glucocorticoids, JAK inhibitors (especially high-dose), TNF inhibitors, and anti-IL-17 agents may be associated with an increased frequency of respiratory viral events. Available data suggest no increased frequency or risk of respiratory viral events with NSAIDs, hydroxychloroquine, sulfasalazine, methotrexate, azathioprine, mycophenolate mofetil, cyclophosphamide, or apremilast. One large cohort study demonstrated an association with leflunomide use and increased risk of acute viral respiratory events compared to non-use. This scoping review identified that some medication classes may confer increased risk of acute respiratory viral infections. However, definitive data are lacking and future studies should address this knowledge gap.

Identifiants

DOI: 10.1016/j.semarthrit.2020.07.007 PMID: 32931985 PMC: PMC7832282
pubmed: 32931985
pii: S0049-0172(20)30209-2
doi: 10.1016/j.semarthrit.2020.07.007
pmc: PMC7832282
pii:
doi:

Substances chimiques

Antirheumatic Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1191-1201

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Mod Rheumatol. 2013 May;23(3):430-9
pubmed: 22833377
Ann Rheum Dis. 2017 Sep;76(9):1550-1558
pubmed: 28473423
Ann Rheum Dis. 2017 Sep;76(9):1575-1582
pubmed: 28450313
Lancet. 2016 Jun 25;387(10038):2630-2640
pubmed: 27156934
Arthritis Rheum. 2010 Jun;62(6):1792-802
pubmed: 20191582
Arthritis Res Ther. 2017 Jan 25;19(1):15
pubmed: 28122642
PLoS Med. 2019 Sep 12;16(9):e1002901
pubmed: 31513665
Arthritis Rheum. 2006 Jul;54(7):2136-46
pubmed: 16802350
N Engl J Med. 2019 Aug 15;381(7):614-625
pubmed: 31050279
Lupus. 2013 Feb;22(2):144-54
pubmed: 23213069
J Am Soc Nephrol. 2009 May;20(5):1103-12
pubmed: 19369404
Arthritis Rheum. 2012 Oct;64(10):3364-73
pubmed: 22674457
Mod Rheumatol. 2013 Jul;23(4):709-15
pubmed: 22791271
Ann Rheum Dis. 2016 Jun;75(6):1057-64
pubmed: 26672064
J Am Acad Dermatol. 2015 Jul;73(1):37-49
pubmed: 26089047
Ann Intern Med. 2020 Mar 17;172(6):369-380
pubmed: 32066146
Lancet. 2015 Sep 19;386(9999):1137-46
pubmed: 26135703
Rheumatology (Oxford). 2007 Jul;46(7):1122-5
pubmed: 17470434
Arthritis Res Ther. 2011;13(5):R141
pubmed: 21884601
Blood. 2011 Feb 3;117(5):1499-506
pubmed: 21098742
Int J Rheum Dis. 2016 Nov;19(11):1143-1156
pubmed: 26259617
Lancet. 2018 Jun 23;391(10139):2503-2512
pubmed: 29908669
Lancet. 2009 Feb 21;373(9664):633-40
pubmed: 19217154
Ann Rheum Dis. 2014 Dec;73(12):2094-100
pubmed: 23918037
Rheumatology (Oxford). 2018 Mar 1;57(3):470-479
pubmed: 29216396
Clin Rheumatol. 2019 Jul;38(7):2001-2009
pubmed: 31016581
J Am Soc Nephrol. 2009 Apr;20(4):901-11
pubmed: 19297556
J Am Acad Dermatol. 2018 Aug;79(2):266-276.e5
pubmed: 29660425
Ann Rheum Dis. 2013 Mar;72(3):381-9
pubmed: 22661646
J Rheumatol. 2007 Sep;34(9):1832-6
pubmed: 17659759
Arthritis Care Res (Hoboken). 2017 Oct;69(10):1484-1494
pubmed: 28622454
Lancet. 2018 Jun 23;391(10139):2513-2524
pubmed: 29908670
Arthritis Rheum. 2005 Oct;52(10):3279-89
pubmed: 16200601
Gastroenterology. 2004 Jan;126(1):19-31
pubmed: 14699483
Lancet. 2018 Jul 14;392(10142):134-144
pubmed: 29961640
Arthritis Res Ther. 2010;12(2):R67
pubmed: 20398273
Ann Rheum Dis. 2005 Aug;64(8):1150-7
pubmed: 15677701
Arthritis Rheum. 2004 Jul;50(7):2264-72
pubmed: 15248226
Clin Rheumatol. 2018 Aug;37(8):2081-2086
pubmed: 29667100
Lancet. 2008 Aug 2;372(9636):375-82
pubmed: 18635256
Arthritis Rheum. 2003 Jan;48(1):35-45
pubmed: 12528101
Lancet Respir Med. 2016 Sep;4(9):708-719
pubmed: 27469583
Ann Rheum Dis. 2012 Mar;71(3):327-33
pubmed: 22021864
J Rheumatol. 2006 Dec;33(12):2412-5
pubmed: 17143978
J Gastroenterol Hepatol. 2010 Nov;25(11):1732-8
pubmed: 21039834
Arthritis Rheumatol. 2020 Oct;72(10):1600-1606
pubmed: 32506699
J Rheumatol. 2014 Mar;41(3):414-21
pubmed: 24429175
Clin Rheumatol. 2016 Oct;35(10):2585-9
pubmed: 27448151
J Rheumatol. 2007 Nov;34(11):2201-3
pubmed: 17937473
Lupus. 2009 Jul;18(8):682-9
pubmed: 19502263
Arthritis Rheum. 2004 Apr 15;51(2):228-32
pubmed: 15077264
N Engl J Med. 2005 Nov 24;353(21):2219-28
pubmed: 16306519
Int J Rheum Dis. 2020 Feb;23(2):256-261
pubmed: 31976619
Clin Ther. 2005 Jan;27(1):64-77
pubmed: 15763607
Nephrology (Carlton). 2005 Oct;10(5):504-10
pubmed: 16221103
J Rheumatol. 2019 Jan;46(1):7-18
pubmed: 30219772
Arthritis Rheum. 2004 May;50(5):1400-11
pubmed: 15146409
Clin Rheumatol. 2020 Mar;39(3):853-860
pubmed: 31732822
Arthritis Rheum. 1997 Dec;40(12):2187-98
pubmed: 9416856
Arthritis Res Ther. 2018 Aug 15;20(1):178
pubmed: 30111357
Ann Rheum Dis. 2019 Apr;78(4):456-464
pubmed: 30679153
Lancet. 2013 Aug 31;382(9894):780-9
pubmed: 23769296
RMD Open. 2020 Feb;6(1):
pubmed: 32396523
Arthritis Rheum. 2008 Nov;58(11):3402-12
pubmed: 18975305
Arthritis Res Ther. 2020 Jan 21;22(1):14
pubmed: 31964419
Clin Rheumatol. 2019 Apr;38(4):1025-1030
pubmed: 30448935
Ann Rheum Dis. 2020 Sep;79(9):1156-1162
pubmed: 32457048
Lancet. 2016 Jul 23;388(10042):343-355
pubmed: 27287832
Arthritis Rheumatol. 2016 Jan;68(1):46-55
pubmed: 26473751
Lancet Gastroenterol Hepatol. 2018 Oct;3(10):671-680
pubmed: 30056030
Arthritis Rheumatol. 2016 Dec;68(12):2867-2877
pubmed: 27389975
Lupus. 2008 Apr;17(4):295-9
pubmed: 18413410
Ann Rheum Dis. 2015 Jun;74(6):1065-71
pubmed: 24608404
Arthritis Rheumatol. 2014 Nov;66(11):2924-37
pubmed: 25047021
Lancet. 2019 Dec 7;394(10214):2108-2117
pubmed: 31732180
Int J Rheumatol. 2017;2017:6730812
pubmed: 29181029
Ann Rheum Dis. 2021 May;80(5):e62
pubmed: 32546603
Ann Rheum Dis. 2020 Aug;79(8):1007-1013
pubmed: 32444415
RMD Open. 2020 Feb;6(1):
pubmed: 32396522
Lancet. 2020 Jan 4;395(10217):53-64
pubmed: 31813637
J Rheumatol. 2018 Feb;45(2):170-176
pubmed: 29142041
J Eur Acad Dermatol Venereol. 2017 Jan;31(1):89-95
pubmed: 27504914
N Engl J Med. 2020 Jan 16;382(3):211-221
pubmed: 31851795
J Rheumatol. 2020 Apr;47(4):518-523
pubmed: 31203225
Arthritis Rheum. 2007 May;56(5):1424-32
pubmed: 17469099
Ann Rheum Dis. 2014 Jun;73(6):990-9
pubmed: 24482301
Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i171-81
pubmed: 25805747
N Engl J Med. 2017 Oct 19;377(16):1537-1550
pubmed: 29045212
Arthritis Rheum. 2005 Apr;52(4):1227-36
pubmed: 15818699
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Arthritis Rheum. 2013 Feb;65(2):464-71
pubmed: 23124321
J Rheumatol. 2018 Mar;45(3):367-377
pubmed: 29247148
Ann Rheum Dis. 2020 Jun;79(6):837-839
pubmed: 32332072
Lancet. 2018 Dec 8;392(10163):2441-2451
pubmed: 30360964
Lancet. 2018 Dec 1;392(10162):2378-2387
pubmed: 30360970
Lupus. 1999;8(7):545-51
pubmed: 10483033
Clin Ther. 2013 Apr;35(4):486-97
pubmed: 23587268
Rheumatology (Oxford). 2007 Jul;46(7):1157-60
pubmed: 17478469
N Engl J Med. 2011 Nov 17;365(20):1886-95
pubmed: 22087680
Arthritis Rheumatol. 2019 Jul;71(7):1112-1124
pubmed: 30747501
Rheumatology (Oxford). 2014 Dec;53(12):2232-7
pubmed: 24996908
Ann Rheum Dis. 2020 Jul;79(7):859-866
pubmed: 32471903
Aliment Pharmacol Ther. 2012 Jan;35(2):275-83
pubmed: 22142227
Arthritis Rheum. 2013 Oct;65(10):2661-71
pubmed: 23896980
Respirology. 2014 Apr;19(3):353-9
pubmed: 24286447
Ann Rheum Dis. 2016 Jan;75(1):30-6
pubmed: 25550339
Semin Arthritis Rheum. 2020 Aug;50(4):564-570
pubmed: 32425260
Arthritis Rheum. 2006 Feb;54(2):628-34
pubmed: 16447241
Arthritis Rheum. 2006 Jan;54(1):26-37
pubmed: 16385520
Arthritis Care Res (Hoboken). 2011 Aug;63(8):1150-8
pubmed: 21584942
Arthritis Rheumatol. 2020 Aug;72(8):1241-1251
pubmed: 32349183
Mod Rheumatol. 2014 May;24(3):410-8
pubmed: 24252050
J Rheumatol. 2019 Mar;46(3):251-258
pubmed: 30504509
Reumatol Clin. 2015 Jul-Aug;11(4):221-3
pubmed: 25455720
J Pediatr. 2013 Jun;162(6):1252-8, 1258.e1
pubmed: 23269206
Ann Rheum Dis. 2014 Jan;73(1):39-47
pubmed: 24013647
Scand J Rheumatol. 2009 Mar-Apr;38(2):133-43
pubmed: 19165648
Ann Rheum Dis. 2006 Aug;65(8):1006-12
pubmed: 16396977
J Dtsch Dermatol Ges. 2012 Nov;10(11):821-37
pubmed: 22934607
Arthritis Rheumatol. 2016 Jan;68(1):56-66
pubmed: 26315675
J Rheumatol. 2014 Dec;41(12):2447-51
pubmed: 25320223
Medicine (Baltimore). 2011 Mar;90(2):139-145
pubmed: 21358439
Rheumatology (Oxford). 2012 Aug;51(8):1368-77
pubmed: 22344575
N Engl J Med. 2017 Oct 19;377(16):1525-1536
pubmed: 29045207
Ann Rheum Dis. 2018 Jun;77(6):890-897
pubmed: 29550766
J Eur Acad Dermatol Venereol. 2013 Mar;27(3):e376-83
pubmed: 23030767
Med Res Arch. 2017 Mar;5(3):
pubmed: 29276769
Rheumatology (Oxford). 2010 Jan;49(1):82-90
pubmed: 19906833
Arthritis Rheum. 2012 Apr;64(4):1215-26
pubmed: 22231479
J Pediatr. 2018 Oct;201:166-175.e3
pubmed: 30054164
Rheumatol Ther. 2019 Dec;6(4):503-520
pubmed: 31410787
Arthritis Rheumatol. 2017 Feb;69(2):277-290
pubmed: 27860410
Reumatismo. 2012 Dec 11;64(5):299-306
pubmed: 23256105
Arthritis Rheum. 2010 Jan;62(1):222-33
pubmed: 20039413
JAMA. 2019 Jul 23;322(4):315-325
pubmed: 31334793
N Engl J Med. 2000 Nov 30;343(22):1594-602
pubmed: 11096166
Clin Rheumatol. 2009 Feb;28(2):129-37
pubmed: 18766426
Lancet Neurol. 2020 Apr;19(4):298-306
pubmed: 32199095

Auteurs

Adam Kilian (A)

Division of Rheumatology, Department of Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC. Electronic address: AKilian@mfa.gwu.edu.

Yu Pei Chock (YP)

Division of Rheumatology, Department of Medicine, Yale University School of Medicine, New Haven, CT.

Irvin J Huang (IJ)

Division of Rheumatology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.

Elizabeth R Graef (ER)

Division of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Laura A Upton (LA)

Georgetown University School of Medicine, Washington, DC.

Aneka Khilnani (A)

George Washington University School of Medicine and Health Sciences, Washington, DC.

Sonia D Silinsky Krupnikova (SDS)

Division of Rheumatology, Department of Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC.

Ibrahim Almaghlouth (I)

King Saud University College of Medicine, Riyadh, Saudi Arabia.

Laura C Cappelli (LC)

Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

Ruth Fernandez-Ruiz (R)

Division of Rheumatology, Department of Medicine, New York University Langone Health, New York, NY.

Brittany A Frankel (BA)

Division of Rheumatology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.

Jourdan Frankovich (J)

Division of Rheumatology, Department of Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA.

Carly Harrison (C)

Lupus Chat.

Bharat Kumar (B)

Division of Rheumatology, Department of Medicine, University of Iowa, Iowa City, IA.

Kanika Monga (K)

Division of Rheumatology, Department of Medicine, University of Texas Houston, Houston, TX.

Jorge A Rosario Vega (JAR)

Division of Rheumatology, Department of Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA.

Namrata Singh (N)

Division of Rheumatology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.

Jeffrey A Sparks (JA)

Division of Rheumatology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Elaine Sullo (E)

George Washington University School of Medicine and Health Sciences, Washington, DC.

Kristen J Young (KJ)

Division of Rheumatology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX.

Ali Duarte-Garcia (A)

Division of Rheumatology and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.

Michael Putman (M)

Division of Rheumatology, Department of Medicine, Northwestern Medicine, Chicago, IL.

Sindhu Johnson (S)

Division of Rheumatology, Toronto Western Hospital, Mount Sinai Hospital; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.

Rebecca Grainger (R)

Department of Medicine, University of Otago, Wellington, New Zealand.

Zachary S Wallace (ZS)

Clinical Epidemiology Program, Division of Rheumatology, Allergy and Immunology, Massachuse General Hospital and Harvard Medical School, Boston, MA.

Jean W Liew (JW)

Division of Rheumatology, Department of Medicine, University of Washington School of Medicine, Seattle, WA. Electronic address: jwliew@uw.edu.

Aruni Jayatilleke (A)

Division of Rheumatology, Department of Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA. Electronic address: arundathi.jayatilleke@tuhs.temple.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Antirhumatismaux › Acute respiratory viral adverse events during...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Acute respiratory viral adverse events during...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Acute respiratory viral adverse events during...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Facteurs épidémiologiques › Comorbidité › Acute respiratory viral adverse events during...
questionsmedicales.fr › Infection › Maladies virales › Infections à virus à ARN › Infections à Nidovirales › Infections à Coronaviridae › Infections à coronavirus › Acute respiratory viral adverse events during...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Acute respiratory viral adverse events during...
questionsmedicales.fr › Phénomènes du système immunitaire › Sujet immunodéprimé › Acute respiratory viral adverse events during...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Épidémies › Pandémies › Acute respiratory viral adverse events during...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › Acute respiratory viral adverse events during...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies du tissu conjonctif › Rhumatismes › Acute respiratory viral adverse events during...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Appréciation des risques › Acute respiratory viral adverse events during...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Acute respiratory viral adverse events during...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Enquêtes de santé › Indicateurs d'état de santé › Acuité des besoins du patient › Indice de gravité de la maladie › Acute respiratory viral adverse events during...